Neurogene, Inc. (NGNE)
28.31
-2.94
(-9.41%)
USD |
NASDAQ |
Sep 25, 16:00
28.32
+0.01
(+0.04%)
After-Hours: 19:59
Neurogene Total Liabilities (Quarterly) : 27.23M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 27.23M |
| March 31, 2026 | 25.36M |
| December 31, 2025 | 24.29M |
| September 30, 2025 | 22.29M |
| June 30, 2025 | 24.06M |
| March 31, 2025 | 23.51M |
| December 31, 2024 | 26.07M |
| September 30, 2024 | 26.71M |
| June 30, 2024 | 24.81M |
| March 31, 2024 | 24.57M |
| December 31, 2023 | 36.55M |
| September 30, 2023 | 14.35M |
| June 30, 2023 | 14.43M |
| March 31, 2023 | 17.10M |
| December 31, 2022 | 255.00M |
| September 30, 2022 | 20.93M |
| June 30, 2022 | 20.31M |
| March 31, 2022 | 19.03M |
| December 31, 2021 | 20.40M |
| September 30, 2021 | 21.07M |
| June 30, 2021 | 19.95M |
| March 31, 2021 | 21.14M |
| December 31, 2020 | 19.30M |
| September 30, 2020 | 21.35M |
| June 30, 2020 | 16.62M |
| Date | Value |
|---|---|
| March 31, 2020 | 15.93M |
| December 31, 2019 | 5.336M |
| September 30, 2019 | 2.916M |
| June 30, 2019 | 1.414M |
| March 31, 2019 | 3.892M |
| December 31, 2018 | 4.946M |
| September 30, 2018 | 11.09M |
| June 30, 2018 | 13.75M |
| March 31, 2018 | 9.798M |
| December 31, 2017 | 11.44M |
| September 30, 2017 | 7.51M |
| June 30, 2017 | 8.676M |
| March 31, 2017 | 6.386M |
| December 31, 2016 | 9.716M |
| September 30, 2016 | 8.706M |
| June 30, 2016 | 8.611M |
| March 31, 2016 | 5.829M |
| December 31, 2015 | 4.923M |
| September 30, 2015 | 4.001M |
| June 30, 2015 | 4.049M |
| March 31, 2015 | 5.051M |
| December 31, 2014 | 5.276M |
| September 30, 2014 | 4.636M |
| June 30, 2014 | 2.939M |
| March 31, 2014 | 1.352M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 244.36M |
| Shareholders Equity (Quarterly) | 217.13M |
| Debt to Equity Ratio | 0.0384 |
| Current Ratio | 10.63 |
| Net Debt Paydown Yield | 0.14% |